Full-Time

Sr. Director

Clinical Quality Assurance

Posted on 7/15/2024

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology

Compensation Overview

$220k - $265kAnnually

+ Performance Bonus + Equity + Health Benefits

Senior, Expert

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor's degree in a scientific discipline or equivalent experience
  • Minimum of 8 years of experience in a GCP practice area; Clinical Quality Assurance or similar role preferred
  • Expertise with applicable GCP guidelines
Responsibilities
  • Identify opportunities for process improvement and lead initiatives to enhance efficiency, effectiveness, and compliance
  • Implement best practices and standardized processes to optimize quality assurance activities
  • Foster a culture of continuous improvement and innovation across the organization
  • Lead (or support) mock inspections, identify potential compliance gaps, and implement corrective actions as needed
  • Lead internal audits
  • Lead or support external audits, as deemed necessary
  • Review vendor, site and internal audit responses for adequacy and identify and propose relevant sponsor process improvement tasks/initiatives
  • Develop, review, and revise Standard Operating Procedures (SOPs) to ensure alignment with regulatory standards and industry best practices
  • Ensure SOPs are clear, comprehensive, and accessible to relevant stakeholders
  • Work closely with clinical study teams to ensure/coordinate appropriate documentation of quality event management, including corrective action and preventive action (CAPA) plans
  • Establish key quality metrics and performance indicators to monitor the effectiveness of clinical quality assurance activities
  • Analyze data trends, identify areas for improvement, and implement corrective and preventive actions to drive continuous quality improvement
  • Prepare comprehensive reports and presentations on quality assurance metrics and initiatives for senior management
  • Other duties as assigned or required

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company uses a decentralized subsidiary model, allowing each subsidiary to concentrate on specific therapies while sharing central resources. This structure enhances efficiency and enables the advancement of multiple drug programs at once. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Their goal is to create significant therapeutic improvements by targeting diseases at their genetic source. With over 15 drug programs aimed at 20 different genetic diseases, BridgeBio aims to bring treatments to market more quickly than traditional biopharma processes. The company promotes a culture of independent thinking and transparency, which supports rapid, data-driven decision-making.

Company Stage

IPO

Total Funding

$704.4M

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investment by Norges Bank shows strong investor confidence in BridgeBio.
  • Partnership with PANTHERx Rare enhances market penetration for rare disease therapies.
  • KRAS inhibitors development positions BridgeBio in a promising cancer treatment market.

What critics are saying

  • Alnylam's RNAi therapy poses competitive pressure on BridgeBio's Attruby.
  • Decentralized model may challenge cohesive strategic direction across programs.
  • Increased competition in KRAS inhibitors could impact BridgeBio's market share.

What makes BridgeBio unique

  • BridgeBio employs a decentralized subsidiary model for efficient drug development.
  • Focus on genetic diseases allows targeting conditions with well-understood genetic causes.
  • Partnerships with specialty pharmacies enhance patient access to rare disease therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Performance Bonus

Company Equity

Unlimited Paid Time Off

INACTIVE